Usefulness of Mean Nocturnal Basal Impedance in Patients with Suspected Non-Erosive Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors
DOI:
https://doi.org/10.52787/agl.v52i3.238Keywords:
Basal impedance, mean nocturnal basal impedance, gastroesophageal reflux disease, diagnosisAbstract
Introduction. When the acid exposure time is inconclusive (4-6%), complementary findings such as the mean nocturnal basal impedance could collaborate in the diagnosis of the presence or absence of gastroesophageal reflux disease. In this study we consider the usefulness of mean nocturnal basal impedance in clinical practice for the diagnosis of gastroesophageal reflux disease.
Objectives. Our objectives were to compare mean nocturnal basal impedance in patients with suspected non-erosive reflux disease versus healthy controls and in patients with different levels of acid exposure time, to determine the association between mean nocturnal basal impedance and classical impedance-pH measurements, and explore the added diagnostic value of mean nocturnal basal impedance in the inconclusive area of acid exposure time.
Patients and methods. We conducted a prospective observational study in a tertiary care center in the Autonomous City of Buenos Aires, Argentina, between January 2017 and December 2018. Consecutive patients older than 18 years referred for typical symptoms of gastroesophageal reflux disease without proton pump inhibitors response were included. Patients older than 18 years of age referred consecutively for extraesophageal symptoms, in whom the presence of gastroesophageal reflux disease was ruled out, were considered the control group. All patients underwent upper digestive video endoscopy, high-resolution esophageal manometry and 24-hour ambulatory pH-impedance measurement, after discontinuing proton pump inhibitors for 4 weeks.
Results. 59 patients with suspected non-erosive reflux disease refractory to proton pump inhibitors treatment and 17 controls were included. In patients with suspected non-erosive reflux disease, a significant difference was found in mean nocturnal basal impedance between the 3 acid exposure time groups analyzed. There was a moderate negative correlation between mean nocturnal basal impedance and acid exposure time, number of reflux episodes and hiatal hernia size. Of the 7 patients with inconclusive acid exposure time, 5 patients (71.4%) had a mean nocturnal basal impedance < 2292 Ohms and responded to a double dose of proton pump inhibitors. The remaining two patients with moderate negative correlation between > 2292 Ohms did not respond to double-dose proton pump inhibitors.
Conclusion. Our study reflects a real-world approach to the evaluation and management of gastroesophageal reflux disease. Our findings support the use of mean nocturnal basal impedance in clinical practice as a complementary element to add confidence in the evaluation of the presence of gastroesophageal reflux disease, especially when acid exposure time is inconclusive.
References
-1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, and the Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-1920.
-2. Katz P, Gerson L, Vela M. Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol 2013;108:308-328.
-3. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710-717.
-4. Chiocca JC, Olmos JA, Salis GB, Soifer LO, Higa R, Marcolongo M. Prevalence, clinical spectrum and atypical symptoms of gastro-oesophageal reflux in Argentina: a nationwide population-based study. Aliment Pharmacol Ther 2005;22:331-342.
-5. Olmos JA, Ramos RI, Argonz J, Lozzi RD, Higa R, Gadea O, Perretta CJ, Caro LE, Cerisoli CL, Landoni NA, Salis G. Spectrum of endoscopic findings in patients with symptoms related to gastro-oesophageal reflux disease (GERD) in Argentina. Nationwide epidemiological study. Gastroenterology 2009;136:A489-A490.
-6. Boeckxstaens G, El-Serag H, Smout A, Kahrilas P. Symptomatic reflux disease: the present, the past and the future. Gut 2014;63:1185-1193.
-7. A Barlow WJ, Orlando RC. The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis. Gastroenterology 2005;128:771-778.
-8. Farré R. Pathophysiology of gastro-esophageal reflux disease: a role for mucosa integrity? Neurogastroenterol Motil 2013;25:783-799.
-9. Hopwood D, Milne G, Logan KR. Electron microscopic changes in human oesophageal epithelium in oesophagitis. J Phatol 1979;129:161-167.
-10. Tobey NA, Carson JL, Alkiek RA, Orlando RC. Dilated intercellular spaces: a morphological feature of acid reflux-damaged human esophageal epithelium. Gastroenterology 1996;111:1200-1205.
-11. Caviglia R, Ribolsi M, Gentile M, Rabitti C, Emerenziani S, Guarino MP, Petitti T, Cicala M. Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2007;25:629-636.
-12. Neumann H, Mönkemüller K, Fry LC, Dombrowski F, Kuester D, Beyer M, Malfertheiner P. Intercellular space volume is mainly increased in the basal layer of esophageal squamous epithelium in patients with GERD. Dig Dis Sci 2011;56:1404-1411.
-13. Tobey NA, Carson JL, Alkiek RA, Orlando RC. Dilated intercellular spaces: a morphological feature of acid reflux-damaged human esophageal epithelium. Gastroenterology 1996;111:1200-5.
-14. Orlando RC, Powell DW, Carney CN. Pathophysiology of acute acid injury in rabbit esophageal epithelium. J Clin Invest 1981;68:286-93.
-15. Carney CN, Orlando RC, Powell DW, Dotson MM. Morphologic alterations in early acid-induced epithelial injury of the rabbit esophagus. Lab Invest 1981;45:198-208.
-16. Tobey NA, Hosseini SS, Argote CM, Dobrucali AM, Awayda MS, Orlando RC. Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium. Am J Gastroenterol 2004;99:13-22.
-17. Carlsson R, Fandriks L, Jonsson C, Lundell L, Orlando RC. Is the esophageal squamous epithelial barrier function impaired in patients with gastroesophageal reflux disease? Scand J Gastroenterol 1999;34:454-8.
-18. Farre R, Fornari F, Blondeau K,Vieth M, De Vos R, Bisschops R. Acid and weakly acidic solutions impair mucosal integrity of distal exposed and proximal non-exposed human oesophagus. Gut 2010;59:164-9.
-19. Villanacci V, Grigolato PG, Cestari R, et al. Dilated intercellular spaces as markers of reflux disease: histology, semiquantitative score and morphometry upon light microscopy. Digestion 2001;64:1-8.
-20. Van Malenstein H, Farre R, Sifrim D. Esophageal dilated intercellular spaces (DIS) and nonerosive reflux disease. Am J Gastroenterol 2008;103:1021-8.
-21. Scarpignato C, Micali B, Galmiche JP. Transmucosal potential difference as an index of esophageal mucosal integrity. Digestion 1995;56:51-60.
-22. Kidder GW III, Lillemoe KD, Harmon JW, Maydonovitch CL, Bunte RM, Johnson LF. Evaluation of in vivo measurement of transesophageal electrical resistance as an indicator or early experimental esophageal mucosal injury. J Lab Clin Med 1983;102:477-86.
-23. Van Wijk MP, Sifrim D, Rommel N, Benninga MA, Davidson GP, Omari TI. Characterization of intraluminal impedance patterns associated with gas reflux in healthy volunteers. Neurogastroenterol Motil 2009;21:825-e55.
-24. Al-Zaben A, Chandrasekar V. Effect of esophagus status and catheter configuration on multiple intraluminal impedance measurements. Physiol Means 2005;26:229-38.
-25. Sifrim D, Zhang X, Emerenziani S, et al. Patients with severe esophagitis and Barrett´s esophagus have a distinctive low intraluminal impedance. A screening test? Gut 2004;53 (Suppl VI): A111. Ref Type: Abstract.
-26. Farré R, Blondeau K, Clement D, Vicario M, Cardozo L, Vieth M, Mertens V, Pauwels A, Silny J, Jimenez M, Tack J, Sifrim D. Evaluation of esophageal mucosal integrity by the intraluminal impedance technique. Gut 2011;60:885-892.
-27. Frazzoni M, Savarino E, de Bortoli N,Martinucci I, Furnari M, Frazzoni L, et al. Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Impedance-pH Monitoring of Patients With Reflux Disease. Clin Gastroenterol Hepatol 2016;14:40-46.
-28. Gyawali CP, Kahrilas PJ, Savarino E, Zerbib F, Mion F, Smout AJPM et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018 Jul;67(7):1351-1362.
-29. Martinucci I, de Bortoli N, Savarino E, Piaggi P, Bellini M, Antonelli A et al. Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil. 2014 Apr;26(4):546-55.
-30. Rengarajan A, Savarino E, Della Coletta M, Ghisa M, Patel A et al. Mean Nocturnal Baseline Impedance Correlates With Symptom Outcome When Acid Exposure Time Is Inconclusive on Esophageal Reflux Monitoring. Clin Gastroenterol Hepatol. 2020 Mar;18(3):589-595.
-31. Ribolsi M, Frazzoni M, Marabotto E, De Carlo G, Ziola S, Maniero D et al. Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus. Aliment Pharmacol Ther. 2021 Aug;54(4):412-418.
-32. Sifrim D, Roman S, Savarino E, et al. Normal values and regional differences in oesophageal impedance-pH metrics: a consensus analysis of impedance-pH studies from around the world. Gut 2020;0:1-9.

Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Mercedes Manresa, Tatiana Uehara, Harumi Hashimoto, Juan Montero, Esteban González Ballerga, Adriana Tevez

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.